News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic
News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic
复制标题
DOI：
10.1377/hlthaff.2018.05075
复制
发表时间：
2019-04-01
期刊：
影响因子：
9.7
通讯作者：
Barry, Colleen L.
中科院分区：
文献类型：
--
作者：
Kennedy-Hendricks, Alene;Levin, Jonathan;Barry, Colleen L.
美沙酮和丁丙诺啡等药物是治疗阿片类药物使用障碍(OUD)的有效药物，但使用率仍然很低。鉴于新闻媒体作为公众健康信息来源的重要性，以及它在形成有关这些药物的知识方面的作用，我们审查了关于在阿片类药物危机中进行OUD药物治疗的报道。通过对新闻媒体报道的分析，可以洞察围绕这一问题的公众对话。在2007-16年期间，使用标准化的搜索词来查询发行量/收视率高的美国新闻来源，以寻找关于OUD药物的报道。2015-16年度，有关这些药物的新闻报道大幅增加。在阿片类药物过量使用率较高的州，当地新闻报道强调了使用OUD药物的负面影响多于积极后果。在有关这些药物的新闻报道中，只有不到40%的人提到它们没有得到充分利用。尽管成瘾专家认为OUD药物的使用不足是抗击阿片类药物危机的一个重大障碍，但我们的发现表明，在大多数新闻媒体对这些药物的报道中，使用不足并不是一个问题。公共卫生和成瘾专家需要制定更有效的战略，传播有关这些药物在减少阿片类药物相关发病率和死亡率方面的价值的信息。
Medications such as methadone and buprenorphine are effective treatments for opioid use disorder (OUD), but levels of use remain low. Given the importance of the news media as a source of health information for the public and its role in shaping knowledge about these medications, we examined reporting on OUD medication treatment amid the opioid crisis. Analyzing news media reporting can provide insight into the public dialogue around this issue. Standardized search terms were used to query high-circulation/viewership US news sources in the period 2007-16 for stories about OUD medications. News reporting about the medications increased substantially in 2015-16. Local news coverage in states with high opioid overdose rates highlighted more negative than positive consequences of OUD medication use. Fewer than 40 percent of news stories about the medications mentioned that they were underused. Although addiction experts view underuse of OUD medications as a significant barrier to combating the opioid crisis, our findings suggest that underuse has not been framed as a problem in most news media reporting on these medications. Public health and addiction experts need to develop more effective strategies for disseminating information on the value of these medications in reducing opioid-related morbidity and mortality.